正壓呼吸器市場規模、佔有率和成長分析（按產品類型、應用、最終用戶和地區）- 產業預測 2025-2032

預計 2023 年正壓呼吸器的市場規模將達到 22.7 億美元，並從 2024 年的 23.9 億美元成長到 2032 年的 35.8 億美元，預測期內（2025-2032 年）的複合年成長率為 5.2%。

全球正壓呼吸器(PAP)設備市場正在持續成長，這得益於人們對睡眠呼吸中止症等睡眠相關呼吸障礙的認知和診斷的不斷提高。這些情況對整體健康有重大影響，推動了對有效治療方案的需求，例如非侵入性、呼吸增強型持續性陽壓呼吸器(CPAP) 和雙水平氣道正壓通氣 (BiPAP) 機器。主要成長動力包括醫療保健支出的增加、提高舒適度的技術進步以及更容易出現睡眠障礙的老齡化人口。製造商、醫療保健提供者和研究機構之間的合作正在推動創新。然而，包括患者依從性、成本問題和監管障礙在內的挑戰正迫使該行業進行調整，迫使公司改進產品、加強分銷，同時投資於教育和推廣工作，以提高人們對 PAP 治療的接受度。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局
• 專利分析
• 技術分析

正壓呼吸器市場規模（依產品類型及複合年成長率） (2025-2032)

• 市場概況
• 持續性呼吸道正壓通氣 (CPAP)
• 自動正壓呼吸裝置(APAP)
• 雙正壓呼吸器(BiPAP)

正壓呼吸器市場規模（按應用分類）及複合年成長率（2025-2032）

• 市場概況
• 阻塞型睡眠呼吸中止症
• 呼吸衰竭
• 慢性阻塞性肺病(COPD)
• 其他

正壓呼吸器市場規模（按最終用戶和複合年成長率分類）（2025-2032 年）

• 市場概況
• 醫院
• 家庭醫療保健
• 睡眠實驗室和診所

正壓呼吸器市場規模（按地區分類）及複合年成長率（2025-2032 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• ResMed Inc.（USA）
• Koninklijke Philips NV（Netherlands）
• Fisher & Paykel Healthcare Corporation Limited（New Zealand）
• DeVilbiss Healthcare LLC（USA）
• Drive Medical（USA）
• 3B Medical, Inc.（USA）
• Apex Medical Corp.（Taiwan）
• BMC Medical Co., Ltd.（China）
• Somnetics International, Inc.（USA）
• Invacare Corporation（USA）
• Medtronic plc（Ireland）
• Vyaire Medical, Inc.（USA）
• Compumedics Limited（Australia）
• Lowenstein Medical Innovation GmbH & Co. KG（Germany）
• Teijin Pharma Limited（Japan）
• Nihon Kohden Corporation（Japan）
• Itamar Medical Ltd.（Israel）
• Circadiance LLC（USA）
• Breas Medical AB（Sweden）
• Weinmann Emergency Medical Technology GmbH+Co. KG（Germany）

結論和建議

Positive Airway Pressure Devices Market size was valued at USD 2.27 billion in 2023 and is poised to grow from USD 2.39 billion in 2024 to USD 3.58 billion by 2032, growing at a CAGR of 5.2% during the forecast period (2025-2032).

The global Positive Airway Pressure (PAP) device market is experiencing consistent growth fueled by heightened awareness and diagnosis of sleep-related breathing disorders like sleep apnea. These conditions significantly impact overall health, increasing the demand for effective treatment options such as Continuous Positive Airway Pressure (CPAP) and Bi-level Positive Airway Pressure (BiPAP) machines, which are non-invasive and enhance breathing. Key growth drivers include rising healthcare expenditures, technological advancements improving comfort, and an aging population more prone to sleep disorders. Collaborative efforts among manufacturers, healthcare providers, and research institutions are fostering innovation. However, challenges like patient adherence, cost concerns, and regulatory hurdles necessitate industry adjustments, compelling companies to refine their products and enhance distribution while investing in educational outreach to promote acceptance of PAP therapy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Positive Airway Pressure Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Positive Airway Pressure Devices Market Segments Analysis

Global Positive Airway Pressure Devices Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Continuous Positive Airway Pressure (CPAP) Devices, Automatic Positive Airway Pressure (APAP) Devices and Bi-level Positive Airway Pressure (BiPAP) Devices. Based on Application, the market is segmented into Obstructive Sleep Apnea, Respiratory Failures, Chronic Obstructive Pulmonary Disease (COPD) and Others. Based on End User, the market is segmented into Hospitals, Home Healthcare and Sleep Laboratories & Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Positive Airway Pressure Devices Market

The rising global incidence of sleep disorders significantly influences the growth of the positive airway pressure (PAP) devices market. These devices are essential for treating conditions such as obstructive sleep apnea (OSA), as they provide an effective primary solution for managing these ailments. By promoting a clear airway during sleep, PAP therapy effectively tackles the root causes of these disorders. As the prevalence of sleep disorders continues to climb, the demand for PAP devices is projected to increase, positioning them as a crucial driver for market expansion in the coming years. Thus, the correlation between sleep disorder rates and PAP device demand underscores a positive market outlook.

Restraints in the Positive Airway Pressure Devices Market

Although Positive Airway Pressure (PAP) devices are highly effective for treating sleep-related breathing disorders, including sleep apnea, many patients face challenges in using them consistently as directed. This non-compliance is often the result of discomfort, poorly fitting masks, and feelings of claustrophobia, all of which can lead to diminished motivation to adhere to therapy. Additionally, a lack of understanding regarding the long-term health benefits associated with PAP use further contributes to this issue. Addressing these adherence barriers is crucial for maximizing the effectiveness of PAP devices and achieving positive health outcomes; however, patient compliance remains a significant obstacle for market growth and success.

Market Trends of the Positive Airway Pressure Devices Market

The Positive Airway Pressure (PAP) devices market is witnessing a significant shift towards remote monitoring and telehealth solutions, driven by advancements in healthcare technology. Manufacturers are increasingly incorporating connectivity features into PAP devices, enabling seamless transmission of therapy data from patients to healthcare providers. This innovation facilitates real-time feedback, improving patient adherence to treatment plans and enhancing overall therapy management. As healthcare increasingly embraces digital solutions, this trend is poised to reshape the PAP devices market, fostering greater patient engagement and optimizing health outcomes. The continued integration of telehealth capabilities is expected to propel market growth well into the future.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis
• Technology Analysis

Global Positive Airway Pressure Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Continuous Positive Airway Pressure (CPAP) Devices
• Automatic Positive Airway Pressure (APAP) Devices
• Bi-level Positive Airway Pressure (BiPAP) Devices

Global Positive Airway Pressure Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Obstructive Sleep Apnea
• Respiratory Failures
• Chronic Obstructive Pulmonary Disease (COPD)
• Others

Global Positive Airway Pressure Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Home Healthcare
• Sleep Laboratories & Clinics

Global Positive Airway Pressure Devices Market Size & CAGR (2025-2032)

• North America (Product Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• ResMed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fisher & Paykel Healthcare Corporation Limited (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DeVilbiss Healthcare LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drive Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3B Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apex Medical Corp. (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BMC Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Somnetics International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invacare Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vyaire Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Compumedics Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lowenstein Medical Innovation GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teijin Pharma Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Itamar Medical Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Circadiance LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Breas Medical AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Weinmann Emergency Medical Technology GmbH + Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations